{"id":"follicle-stimulating-hormone","_fda":{"id":"8c95390f-f204-41d4-a7c8-22a37a5a04ef","set_id":"123f5269-45eb-4dcd-be66-76c6665b8d13","openfda":{"nui":["N0000175838","M0009540","M0017672","N0000175601","N0000175824","N0000000146","M0001109"],"unii":["2334LJD2E9","GO1N1ZPR3B","4964P6T9RB","C24W7J5D5R","97C5T2UQ7J","883WKN7W8X","7L3E358N9L","2DI9HA706A","076WHW89TW","459AG36T1B","4G7DS2Q64Y","S7YTV04R8O","3XMK78S47O"],"route":["ORAL"],"spl_id":["8c95390f-f204-41d4-a7c8-22a37a5a04ef"],"brand_name":["Hormone Harmony"],"spl_set_id":["123f5269-45eb-4dcd-be66-76c6665b8d13"],"package_ndc":["70558-0008-1"],"product_ndc":["70558-0008"],"generic_name":["ACETALDEHYDE, DOPAMINE HYDROCHLORIDE, DHEA (DEHYDROEPIANDROSTERONE), 7-OXO- DEHYDROEPIANDROSTERONE 3-ACETATE, FOLLICULINUM, OOPHORINUM (SUIS), CHOLESTERINUM, PROGESTERONE, TESTOSTERONE, CORTISONE ACETICUM, ALDOSTERONE, ANDROSTERONE, FOLLICLE STIMULATING HORMONE"],"product_type":["HUMAN OTC DRUG"],"pharm_class_cs":["Gonadotropins [CS]","Progesterone [CS]","Androstanes [CS]"],"substance_name":["7-KETO-DEHYDROEPIANDROSTERONE","ACETALDEHYDE","ALDOSTERONE","ANDROSTERONE","CHOLESTEROL","CORTISONE ACETATE","DOPAMINE HYDROCHLORIDE","ESTRONE","FOLLITROPIN","PRASTERONE","PROGESTERONE","SUS SCROFA OVARY","TESTOSTERONE"],"pharm_class_epc":["Gonadotropin [EPC]","Progesterone [EPC]","Androgen [EPC]"],"pharm_class_moa":["Androgen Receptor Agonists [MoA]"],"manufacturer_name":["Pro Weight Loss Inc."],"is_original_packager":[true]},"purpose":["HOMEOPATHIC INDICATIONS: Temporary relief of symptoms related to hormone imbalances of insufficiencies in men and women, including low energy, inability to handle stress, trouble focusing, changes in mood, infertility, irregular menstrual cycles (females), and lack of libido.** **These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration."],"version":"3","warnings":["WARNINGS: Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. If pregnant or breast-feeding, ask a healthcare professional before use. Tamper seal: sealed for your protection. Do not use if seal is broken or missing."],"questions":["QUESTIONS: Dist. by Pro Weight Loss Inc., 94 Boylston Cir. Shrewsbury, MA 01545 • 508-842-4600"],"effective_time":"20240122","active_ingredient":["ACTIVE INGREDIENTS: Acetaldehyde 6X, 12X, 30X, 200X, Dopamine Hydrochloride 6X, 12X, 30X, 200X, DHEA (Dehydroepiandrosterone) 6X, 12X, 30X, 200X, 12C, 30C, 60C, 200C, 7-Oxo-Dehydroepiandrosterone 3β-Acetate, 8X, 12X, 30X, 60X, 200X, 12C, 30C, 60C, 200C, Folliculinum 8X, 12X, 30X, 60X, 200X, 12C, 30C, 60C, 200C, Oophorinum (Suis) 8X, 12X, 30X, 60X, 200X, 12C, 30C, 60C, 200C, Cholesterinum 8X, 12X, 30X, 200X, 12C, 30C, 60C, 200C, Progesterone 8X, 12X, 30X, 200X, 12C, 30C, 60C, 200C, Testosterone 8X, 12X, 30X, 200X, 12C, 30C, 60C, 200C, Cortisone Aceticum 12X, 30X, 200X, 12C, 30C, 60C, 200C, Aldosterone 12C, 30C, 60C, 200C, Androsterone 12C, 30C, 60C, 200C, Follicle Stimulating Hormone 12C, 30C, 60C, 200C."],"inactive_ingredient":["INACTIVE INGREDIENTS: demineralized water, 25% ethanol"],"indications_and_usage":["HOMEOPATHIC INDICATIONS: Temporary relief of symptoms related to hormone imbalances of insufficiencies in men and women, including low energy, inability to handle stress, trouble focusing, changes in mood, infertility, irregular menstrual cycles (females), and lack of libido.** **These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration."],"dosage_and_administration":["DIRECTIONS: 1-10 drops under the tongue, 3 times a day or as directed by your health professional. Consult a physician for use in children under 12 years of age."],"spl_product_data_elements":["Hormone Harmony Acetaldehyde, Dopamine Hydrochloride, DHEA (Dehydroepiandrosterone), 7-Oxo- Dehydroepiandrosterone 3-Acetate, Folliculinum, Oophorinum (Suis), Cholesterinum, Progesterone, Testosterone, Cortisone Aceticum, Aldosterone, Androsterone, Follicle Stimulating Hormone ACETALDEHYDE ACETALDEHYDE DOPAMINE HYDROCHLORIDE DOPAMINE PRASTERONE PRASTERONE 7-KETO-DEHYDROEPIANDROSTERONE 7-KETO-DEHYDROEPIANDROSTERONE ESTRONE ESTRONE SUS SCROFA OVARY SUS SCROFA OVARY CHOLESTEROL CHOLESTEROL PROGESTERONE PROGESTERONE TESTOSTERONE TESTOSTERONE CORTISONE ACETATE CORTISONE ALDOSTERONE ALDOSTERONE ANDROSTERONE ANDROSTERONE FOLLITROPIN FOLLITROPIN WATER ALCOHOL"],"keep_out_of_reach_of_children":["KEEP OUT OF REACH OF CHILDREN: Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away."],"package_label_principal_display_panel":["PACKAGE LABEL DISPLAY: NDC 70558-0008-1 Pro Weight Loss HOMEOPATHIC Hormone Harmony 1 FL OZ (30 ml) Hormone Harmony"]},"safety":{"boxedWarnings":[]},"_chembl":{"chemblId":"CHEMBL415111","moleculeType":"Protein","molecularWeight":"1622.88"},"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=follicle stimulating hormone","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T06:04:25.485784+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=follicle stimulating hormone","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T06:04:40.882825+00:00"},"mechanism.drugClass":{"url":"https://api.fda.gov/drug/label.json","method":"deterministic","source":"FDA Label (EPC)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T06:04:24.373432+00:00"},"administration.route":{"url":"","method":"deterministic","source":"FDA Label","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T06:04:24.373502+00:00"},"indications.approved":{"url":"","method":"ai_extraction","source":"FDA Label + AI","aiModel":"featherless","rawText":"","confidence":0.9,"sourceType":"fda_label","retrievedAt":"2026-04-20T06:04:52.358966+00:00"},"safety.boxedWarnings":{"url":"","method":"deterministic","source":"FDA Label (no boxed warning)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T06:04:24.373508+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL415111/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T06:04:42.042764+00:00"}},"_dailymed":{"setId":"421707d6-31c1-4d57-b017-796fc872efe4","title":"HORMONE BALANCE (ACETALDEHYDE, DOPAMINE HYDROCHLORIDE, DHEA (DEHYDROEPIANDROSTERONE), 7-OXO-DEHYDROEPIANDROSTERONE-3B-ACETATE, FOLLICULINUM, OOPHORINUM (SUIS), CHOLESTERINUM, PROGESTERONE, TESTOSTERONE, CORTISONE ACETICUM, ALDOSTERONE, ANDROSTERONE, FOLLICLE STIMULATING HORMONE) LIQUID [DR. DONNA RESTIVO DC]"},"mechanism":{"drugClass":"Gonadotropin [EPC]"},"_scrapedAt":"2026-03-27T23:46:48.357Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":1,"lastValidatedAt":"2026-04-20T06:04:52.641834+00:00","fieldsConflicting":0,"overallConfidence":0.95},"indications":{"approved":[{"id":"follicle-stimulating-hormone-hormone-imbalance-symptoms","name":"Hormone imbalance symptoms","dosing":null,"approvals":[],"diseaseId":"","eligibility":"Men and women","pivotalTrial":null,"restrictions":[],"patientPopulation":"Men and women","diagnosticRequired":null,"brandNameForIndication":""}]},"trialDetails":[{"nctId":"NCT06378268","phase":"NA","title":"PPOS vs GnRH Antagonist in Ovarian Stimulation (ProGanOS Study)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mỹ Đức Hospital","startDate":"2024-04-24","conditions":"Progestins Primed Ovarian Stimulation","enrollment":626},{"nctId":"NCT06433518","phase":"","title":"BEst Size for Ovulation Triggering in Poseidon 4 Patients (BEST 4 Study)","status":"RECRUITING","sponsor":"Centrum Clinic IVF Center","startDate":"2026-03-15","conditions":"Fertilization, Fertilization in Vitro","enrollment":200},{"nctId":"NCT07269327","phase":"PHASE1","title":"An Ethno-bridging Study of Pergoveris in Healthy Premenopausal Participants of Japanese or Caucasian Origin","status":"COMPLETED","sponsor":"Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany","startDate":"2025-11-24","conditions":"Fertility","enrollment":24},{"nctId":"NCT02871167","phase":"NA","title":"Risk of Infertility Related to Adjuvant Chemotherapy for Early Breast Cancer: Oocyte/Embryo Cryopreservation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre Oscar Lambret","startDate":"2016-12","conditions":"Breast Cancer","enrollment":140},{"nctId":"NCT07340827","phase":"PHASE3","title":"A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH and FSH Deficiency Undergoing ART (HINATA)","status":"RECRUITING","sponsor":"Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany","startDate":"2026-02-05","conditions":"Infertility","enrollment":333},{"nctId":"NCT07477340","phase":"","title":"Plasma Relaxin Measurement Based on Endometrial Preparation for Embryo Transfer","status":"NOT_YET_RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2026-05-01","conditions":"Infertility, Embryos Transfert","enrollment":60},{"nctId":"NCT04037254","phase":"PHASE1, PHASE2","title":"Testing the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer With a High Chance of Recurring","status":"COMPLETED","sponsor":"NRG Oncology","startDate":"2019-10-08","conditions":"Prostate Adenocarcinoma, Stage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8","enrollment":22},{"nctId":"NCT07153367","phase":"PHASE2","title":"Using a Fixed Dosage of Follitropin Delta for Ovarian Stimulation for Intrauterine Insemination: Rekovelle for Intrauterine Successful Experience (RISE)","status":"RECRUITING","sponsor":"Centre Hospitalier Intercommunal Creteil","startDate":"2025-12-17","conditions":"Infertility, Insemination","enrollment":80},{"nctId":"NCT07466199","phase":"PHASE4","title":"Exogenous Progesterone as Ovulation Trigger","status":"NOT_YET_RECRUITING","sponsor":"Instituto Valenciano de Infertilidade de Lisboa","startDate":"2026-04","conditions":"Ovulation, Ovarian Function, Assisted Reproductive Treatments","enrollment":10},{"nctId":"NCT07457684","phase":"","title":"Comparison of Follitropin Delta and Follitropin Alfa in Combination With Menotropin","status":"COMPLETED","sponsor":"Clinique Ovo","startDate":"2025-12-05","conditions":"IVF Outcomes, OVARIAN STIMULATION","enrollment":846},{"nctId":"NCT07450300","phase":"","title":"Assessment of the Feasibility of Frozen Embryo Transfers in a Natural Cycle Among Obese Compared to Non-Obese Patients","status":"COMPLETED","sponsor":"Clinique Mathilde","startDate":"2022-11-01","conditions":"Infertility, Female","enrollment":1831},{"nctId":"NCT06134479","phase":"PHASE3","title":"Comparison of Sequential CFA vs CFA +rFSH for Elective Fertility Preservation.","status":"COMPLETED","sponsor":"Fundación Santiago Dexeus Font","startDate":"2023-12-12","conditions":"Fertility","enrollment":194},{"nctId":"NCT07097259","phase":"PHASE1","title":"A Study to Assess the Bioequivalence of Follitropin Alfa Solution in Pen and Follitropin Alfa Powder in Vial in Healthy Downregulated Male Participants","status":"COMPLETED","sponsor":"EMD Serono Research & Development Institute, Inc.","startDate":"2025-07-21","conditions":"Hypogonadism","enrollment":55},{"nctId":"NCT07423143","phase":"NA","title":"Menopausal Impact of Opportunistic Salpingectomy for Ovarian Cancer Prevention","status":"NOT_YET_RECRUITING","sponsor":"Umeå University","startDate":"2026-03","conditions":"Menopause, Opportunistic Salpingectomy","enrollment":2100},{"nctId":"NCT06864793","phase":"PHASE1","title":"Study on the Pharmacokinetics and Safety of QL1012D and Gonal-F® in Healthy Female Volunteers","status":"ACTIVE_NOT_RECRUITING","sponsor":"Qilu Pharmaceutical Co., Ltd.","startDate":"2025-04-06","conditions":"Infertility, Female","enrollment":48},{"nctId":"NCT06173869","phase":"PHASE3","title":"A Randomised Trial Comparing the Ovarian Response of a Starting Dose of Either 10 μg or 15 μg Follitropin Delta (FE 999049) to a Starting Dose of Either 150 IU or 225 IU Follitropin Alfa (GONAL-F) in Conventional Regimens in China","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2024-03-29","conditions":"Infertility, Female","enrollment":301},{"nctId":"NCT07348757","phase":"","title":"rFSH vs rFSH+rLH in Dydrogesterone-Based Progestin Protocol: A Prospective Study","status":"RECRUITING","sponsor":"Centrum Clinic IVF Center","startDate":"2026-01-05","conditions":"InVitro Fertilization, Gonadotropins","enrollment":300},{"nctId":"NCT06440850","phase":"PHASE2","title":"Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E Mutation","status":"RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2024-07-15","conditions":"Thyroid Gland Follicular Carcinoma, Thyroid Gland Oncocytic Carcinoma, Thyroid Gland Papillary Carcinoma","enrollment":21},{"nctId":"NCT07148141","phase":"","title":"Impact of Breast Cancer on Human Folliculogenesis","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Hospital, Clermont-Ferrand","startDate":"2019-01-11","conditions":"Breast Cancer Female, Infertility, Female","enrollment":100},{"nctId":"NCT06659692","phase":"PHASE1","title":"Pharmacokinetics of FSH and hCG Following Multiple Dose of Gonadotropins-IBSA.","status":"COMPLETED","sponsor":"IBSA Institut Biochimique SA","startDate":"2024-10-10","conditions":"Ovarian Stimulation, Infertility","enrollment":28},{"nctId":"NCT06781957","phase":"PHASE1","title":"Pharmacokinetics of FSH and hCG After a Single Subcutaneous Injection of Gonadotropins-IBSA","status":"COMPLETED","sponsor":"IBSA Institut Biochimique SA","startDate":"2024-09-15","conditions":"OVARIAN STIMULATION, Infertility","enrollment":29},{"nctId":"NCT07346235","phase":"PHASE3","title":"150 IU vs. 225 IU FSH in Normal Responders: The OPTIMAL-DOSE Trial","status":"NOT_YET_RECRUITING","sponsor":"American Hospital 2 Kosovo","startDate":"2026-03-01","conditions":"Infertility, Female","enrollment":440},{"nctId":"NCT06175832","phase":"PHASE4","title":"PPOS (Progestin Primed Ovarian Stimulation) and Corifollitropin Alfa (CFA) Cross-over Study","status":"RECRUITING","sponsor":"University Hospital, Ghent","startDate":"2025-01-27","conditions":"Ovarian Stimulation, Quality of Life, Preimplantation Genetic Testing","enrollment":60},{"nctId":"NCT04746313","phase":"","title":"Prevalence of Hyperprolactinemia in Systemic Scleroderma","status":"COMPLETED","sponsor":"University Hospital, Lille","startDate":"2021-03-01","conditions":"Sclerosis, Systemic, Scleroderma, Hyperprolactinemia","enrollment":71},{"nctId":"NCT00854373","phase":"PHASE4","title":"Concomitant Administration of FSH With HCG Improves Oocyte Maturation and Quality Double -Blinded Randomized Trial","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2007-06-01","conditions":"Infertility","enrollment":232},{"nctId":"NCT00984399","phase":"NA","title":"Serum Estradiol Levels In Postmenopausal Women With Breast Cancer Receiving Adjuvant Aromatase Inhibitors and Vaginal Estrogen","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2009-09-22","conditions":"Atrophic Vaginitis, Breast Cancer","enrollment":31},{"nctId":"NCT05873725","phase":"","title":"Retrospective Study of High Dose Follitropin Delta in a Mixed Protocol With Human Chorionic Gonadotropin","status":"COMPLETED","sponsor":"Clinique Ovo","startDate":"2023-05-20","conditions":"IVF, Infertility","enrollment":118},{"nctId":"NCT05316129","phase":"PHASE1","title":"Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer","status":"RECRUITING","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2022-04-28","conditions":"Ovarian Cancer","enrollment":10},{"nctId":"NCT04166825","phase":"NA","title":"Ovarian Hyperstimulation and Fibrin Clot Properties.","status":"RECRUITING","sponsor":"Jagiellonian University","startDate":"2019-11-18","conditions":"Fibrin Blood Clot, Infertility, Female, Endometriosis","enrollment":300},{"nctId":"NCT02892942","phase":"PHASE4","title":"NATural Ovarian Stimulation","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2017-01-13","conditions":"Infertility","enrollment":129},{"nctId":"NCT06466486","phase":"PHASE1","title":"An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta During Controlled Ovarian Stimulation","status":"TERMINATED","sponsor":"Ferring Pharmaceuticals","startDate":"2024-06-14","conditions":"Fertility","enrollment":310},{"nctId":"NCT05499052","phase":"","title":"Trial to Assess the Pattern of Use of REKOVELLE® in Women Undergoing In Vitro Fertilisation (IVF) or Intracytoplasmic Sperm Injection (ICSI) Procedures in Routine Clinical Practice","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2022-08-28","conditions":"Controlled Ovarian Stimulation","enrollment":201},{"nctId":"NCT06511791","phase":"PHASE1","title":"An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta at Different Time Intervals During Controlled Ovarian Stimulation.","status":"TERMINATED","sponsor":"Ferring Pharmaceuticals","startDate":"2024-07-15","conditions":"Infertility","enrollment":106},{"nctId":"NCT06879002","phase":"","title":"Comparing IVF/ICSI Cycle Outcomes of Post Ovulation Ovarian Stimulation Protocol With Elonva Without GnRH Antagonist to Follicular Phase Day 2 Stimulation Fixed Day 5 Antagonist Protocol","status":"NOT_YET_RECRUITING","sponsor":"ART Fertility Clinics LLC","startDate":"2025-12-30","conditions":"Stimulation in the Ovary, IVF Outcome","enrollment":252},{"nctId":"NCT06372119","phase":"NA","title":"Letrozole-stimulated Cycle Strategy Versus Artificial Cycle Strategy (LETSACT)","status":"RECRUITING","sponsor":"Mỹ Đức Hospital","startDate":"2024-04-22","conditions":"Embryo Transfer, Irregular Menstruation, Letrozole","enrollment":790},{"nctId":"NCT06193135","phase":"NA","title":"Usefulness of Corifollitropin α as Alternative to Conventional Daily rFSH Protocols in Oocyte Donors Undergoing Pituitary Suppression With Medroxiprogesterona Acetate (MPA)","status":"RECRUITING","sponsor":"Instituto Valenciano de Infertilidad, IVI VALENCIA","startDate":"2025-07-08","conditions":"Infertility, Female, Reproductive Sterility","enrollment":318},{"nctId":"NCT07148921","phase":"","title":"Perception of Pain During Gender Affirming Hormone Therapy","status":"RECRUITING","sponsor":"Medical University of Vienna","startDate":"2024-12-01","conditions":"Transgender Persons, Pain Threshold, Perception of Pain","enrollment":40},{"nctId":"NCT07128394","phase":"NA","title":"Extra Luteinizing Hormone Improve Embryo Quality in IVF Patients With Low LH During Long GnRH-Agonist Treatment","status":"RECRUITING","sponsor":"Nanjing University","startDate":"2024-02-01","conditions":"Infertility, Female, Luteinizing Hormone (LH)","enrollment":590},{"nctId":"NCT07121751","phase":"PHASE4","title":"Optimal Stimulation of Hypo-responders Undergoing in Vitro Fertilization (IVF)","status":"NOT_YET_RECRUITING","sponsor":"Dunamenti REK Istenhegyi IVF Center","startDate":"2025-09-01","conditions":"Hypo-responder, Infertility (IVF Patients), OVARIAN STIMULATION","enrollment":150},{"nctId":"NCT07117682","phase":"NA","title":"Safety and Efficacy of Autologous Adipose-Derived Regenerative Cells (ADRCs) Injection for Improving Diminished Ovarian Reserve","status":"NOT_YET_RECRUITING","sponsor":"Cytori Therapeutics","startDate":"2025-08-25","conditions":"Diminished Ovarian Reserve (DOR), Primary Ovarian Insufficiency (Poi), Ovarian Failure, Premature","enrollment":25},{"nctId":"NCT05379556","phase":"","title":"LOng COvid COmorbidities: Andrological, Reproductive, Sexual Dysfunctions in Patients Recovered From COVID-19","status":"RECRUITING","sponsor":"Federico II University","startDate":"2022-01-27","conditions":"Long Covid-19","enrollment":100},{"nctId":"NCT05293366","phase":"","title":"LOng COvid COmorbidities: Endocrine,Metabolic,Neuropsychiatric,Muscle,Cardiovascular,Pulmonary,Dermatologic Dysfunctions","status":"RECRUITING","sponsor":"Federico II University","startDate":"2022-01-27","conditions":"Long Covid-19","enrollment":100},{"nctId":"NCT05753254","phase":"NA","title":"Effect on Markers of Cardiovascular, Reproductive and Cancer Risk From Firefighting Training","status":"COMPLETED","sponsor":"National Research Centre for the Working Environment, Denmark","startDate":"2023-03-10","conditions":"Reactive Hyperemia, Micro RNA, Heart Rate Variability","enrollment":35},{"nctId":"NCT06936930","phase":"","title":"Reproductive and Mental Health of Patients With Aplastic Anemia","status":"RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2025-03-03","conditions":"Aplastic Anemia, Reproductive Health","enrollment":600},{"nctId":"NCT06997900","phase":"PHASE2","title":"Menopur And Rekovelle Combination Study Version 2.0","status":"RECRUITING","sponsor":"Clinique Ovo","startDate":"2025-07-04","conditions":"IVF, Controlled Ovarian Simulation, Fertility Disorders","enrollment":200},{"nctId":"NCT06995261","phase":"","title":"Follitropin Delta in Long GnRH-agonist Protocol","status":"RECRUITING","sponsor":"Prof. Dr. med. M.Sc. Georg Griesinger","startDate":"2025-07-09","conditions":"Infertility (IVF Patients), Infertility, Infertility Drugs","enrollment":350},{"nctId":"NCT06732843","phase":"","title":"Does Recombinant FSH (rFSH, i.g. Gonal F®) as Compared to Human Menopausal Gonadotrophin (hMG) Affect Telomere Length of Cumulus Cells During Antral Follicle Growth and Impact Blastocyst Status?","status":"RECRUITING","sponsor":"ART Fertility Clinics LLC","startDate":"2025-07-23","conditions":"OVARIAN STIMULATION, Telomere Length, Telomere Length, Mean Leukocyte","enrollment":10},{"nctId":"NCT07076719","phase":"","title":"Cell-free DNA Analysis of Spent Embryo Culture Media as a Non-invasive Approach for Preimplantation Genetic Diagnosis","status":"COMPLETED","sponsor":"Sohag University","startDate":"2023-10-01","conditions":"to Evaluate the Feasibility and Accuracy of Using cfDNA Analysis of Spent Embryo Culture Media as a Non-invasive Approach for PGD","enrollment":20},{"nctId":"NCT06978504","phase":"NA","title":"Impact of Genetic Polymorphisms And DASH Diet On Weight Loss Progression In Climacteric Women With Metabolic Syndrome","status":"RECRUITING","sponsor":"Nutrindo Ideais Research Center","startDate":"2025-04-01","conditions":"Nutrition, Metabolic Syndrome, Obesity","enrollment":30},{"nctId":"NCT05815719","phase":"PHASE4","title":"Continuous Double Ovarian Stimulation.","status":"COMPLETED","sponsor":"Instituto Bernabeu","startDate":"2022-11-17","conditions":"Fertility Issues","enrollment":30},{"nctId":"NCT06921395","phase":"PHASE4","title":"Phase IV Study to Evaluate the Efficacy and Safety of Fang Le Shu Compared to Guo Na Fen for Controlled Ovarian Stimulation in Infertile Women Undergoing in Vitro Fertilization-embryo Transfer (IVF-ET).","status":"RECRUITING","sponsor":"LG Chem","startDate":"2025-02-15","conditions":"Female Infertility","enrollment":248},{"nctId":"NCT05263388","phase":"PHASE3","title":"A Trial to Compare the Ovarian Response of REKOVELLE and GONAL-F in Conventional Dosing in Women Undergoing Controlled Ovarian Stimulation","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2022-07-15","conditions":"Infertility","enrollment":302},{"nctId":"NCT04654039","phase":"","title":"Post-Marketing Surveillance (PMS) Protocol of REKOVELLE Pre-Filled Pen (Follitropin Delta)","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2020-10-26","conditions":"Infertility, Female","enrollment":728},{"nctId":"NCT04202094","phase":"NA","title":"Fertility in Young Adults Who Did (Not) Store Testicular Tissue Before a Treatment Leading to Fertility Problems","status":"ENROLLING_BY_INVITATION","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2020-09-08","conditions":"Childhood Cancer, Hematological Disorders","enrollment":50},{"nctId":"NCT05173597","phase":"","title":"Real-world Evidence on Follitropin Delta Individual Dosing","status":"RECRUITING","sponsor":"University of Luebeck","startDate":"2021-12-08","conditions":"Infertility, Sterility","enrollment":850},{"nctId":"NCT03737253","phase":"NA","title":"Hormone Evaluation in Artificial Reproductive Technology","status":"COMPLETED","sponsor":"Lund University","startDate":"2016-09","conditions":"Female Infertility","enrollment":810},{"nctId":"NCT06154083","phase":"PHASE4","title":"INtensity of OVarian Stimualtion and Euploid Embryos","status":"RECRUITING","sponsor":"Fundación Santiago Dexeus Font","startDate":"2023-12-12","conditions":"Fertility","enrollment":110},{"nctId":"NCT06635538","phase":"NA","title":"One-shot Ovarian Stimulation Protocol (One-shot)","status":"RECRUITING","sponsor":"Fundación Santiago Dexeus Font","startDate":"2024-10-31","conditions":"Infertility, Female","enrollment":20},{"nctId":"NCT06618703","phase":"NA","title":"Brain Irradiation for Childhood Cancer - Endocrine Monitoring During the First Years","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Angers","startDate":"2025-03","conditions":"Endocrine; Deficiency, Hypothalamo-Pituitary Disorder, Radiotherapy Side Effect","enrollment":230},{"nctId":"NCT06572930","phase":"","title":"Serum FSH Monitoring for Identification of an Optimal Range During Ovarian Stimulation","status":"RECRUITING","sponsor":"ART Fertility Clinics LLC","startDate":"2024-12-16","conditions":"Ovarian Stimulation","enrollment":150},{"nctId":"NCT06418347","phase":"PHASE3","title":"Effect of ALA Combined With Letrozole on Polycystic Ovary Syndrome Clinical Outcome in Infertile Females","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2024-04-01","conditions":"Polycystic Ovary Syndrome, Infertility, Female","enrollment":150},{"nctId":"NCT04445025","phase":"EARLY_PHASE1","title":"Comparison Elagolix vs Depot Leuprolide Prior to Frozen Embryo Transfers in Patients With Endometriosis","status":"COMPLETED","sponsor":"Colorado Center for Reproductive Medicine","startDate":"2020-09-01","conditions":"Infertility, Endometriosis","enrollment":30},{"nctId":"NCT06806501","phase":"","title":"Muscle Mass, Quality, and the Menopause: Sex-specific Strategies to Mitigate Sarcopenia in Ageing Populations","status":"RECRUITING","sponsor":"University of Nottingham","startDate":"2024-07-29","conditions":"Healthy","enrollment":18},{"nctId":"NCT06803199","phase":"NA","title":"Effects of LH and FSH on Metabolic Regulation in Cumulus Cells","status":"RECRUITING","sponsor":"Kaohsiung Veterans General Hospital.","startDate":"2024-12-01","conditions":"Unrecognized Condition","enrollment":60},{"nctId":"NCT03976544","phase":"PHASE4","title":"Natural Cycle Versus Hormone Replacement Therapy Cycle for a Frozen-thawed Embryo Transfer in PGT Patients","status":"TERMINATED","sponsor":"CRG UZ Brussel","startDate":"2019-05-25","conditions":"Miscarriage, Frozen Embryo Transfer, Natural Cycle","enrollment":362},{"nctId":"NCT04773353","phase":"PHASE3","title":"Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Indian Women","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2021-12-03","conditions":"Infertility","enrollment":220},{"nctId":"NCT06778733","phase":"EARLY_PHASE1","title":"Effectiveness of Low Dose Gonadotropin Stimulation Protocol Vs High Dose Gonadotropin Protocol in Poor Responders","status":"COMPLETED","sponsor":"University of Athens","startDate":"2022-01-01","conditions":"Female Infertility","enrollment":22},{"nctId":"NCT06778304","phase":"PHASE1","title":"Bioequivalence Clinical Trial of Recombinant Human Follicle-stimulating Hormone JZB30","status":"COMPLETED","sponsor":"West China Second University Hospital","startDate":"2021-01-04","conditions":"Bioequivalence, Healthy Volunteers, Pharmacokinetics","enrollment":48},{"nctId":"NCT05330130","phase":"PHASE1","title":"Impact of FSH Dosage During Ovarian Stimulation for IVF/ICSI in Granulosa Cells","status":"COMPLETED","sponsor":"ART Fertility Clinics LLC","startDate":"2023-07-05","conditions":"Ovarian Function Insufficiency, Fertility Issues, Infertility,Female","enrollment":6},{"nctId":"NCT04997525","phase":"PHASE4","title":"Estradiol and Progesterone Levels Following Frozen Embryo Transfer","status":"COMPLETED","sponsor":"Copenhagen University Hospital at Herlev","startDate":"2021-04-20","conditions":"Infertility","enrollment":305},{"nctId":"NCT05103228","phase":"NA","title":"Cumulative Pregnancy Rate With Lower and Higher Gonadotropin Dose During IVF Among Poor Responders","status":"COMPLETED","sponsor":"Peter Kovacs MD","startDate":"2021-12-02","conditions":"Infertility, Ovarian Dysfunction","enrollment":190},{"nctId":"NCT06729359","phase":"","title":"Polycystic Ovary Syndrome and Urinary Tract Stones: a BMI-Adjusted Analysis in Iraqi Women","status":"COMPLETED","sponsor":"Al-Kindy College of Medicine","startDate":"2024-07-01","conditions":"PCOS (Polycystic Ovary Syndrome), Stone, Urinary, BMI","enrollment":407},{"nctId":"NCT06091436","phase":"PHASE3","title":"To Investigate Efficacy and Safety of a Single Injection of GenSci094 for Ovarian Stimulation Using Daily Recombinant FSH as Reference","status":"COMPLETED","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2023-03-24","conditions":"Infertility","enrollment":176},{"nctId":"NCT06095206","phase":"PHASE1","title":"The Pharmacokinetic and Bioavailability of GenSci094 Before and After a Change in Manufacturing Site","status":"COMPLETED","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2023-09-19","conditions":"Infertility","enrollment":48},{"nctId":"NCT06414096","phase":"PHASE1","title":"Use of Pulsatile Intravenous FSH to Mitigate Reprometabolic Syndrome","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2024-10-01","conditions":"Infertility, Obesity","enrollment":5},{"nctId":"NCT04285892","phase":"NA","title":"Embryo Developmental Potential in a Novel 2-step IVM System","status":"COMPLETED","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2020-07-16","conditions":"In Vitro Maturation of Oocytes","enrollment":23},{"nctId":"NCT05403476","phase":"PHASE2","title":"A Trial to Compare Efficacy and Safety of Follitropin Delta Versus Placebo (Inactive Treatment) in the Treatment of Men With Idiopathic Infertility (Unexplained Reduction of Semen Quality) (ADAM)","status":"TERMINATED","sponsor":"Ferring Pharmaceuticals","startDate":"2022-08-16","conditions":"Male Idiopathic Infertility","enrollment":4},{"nctId":"NCT05936840","phase":"","title":"Quantum Menstrual Health Monitoring Study","status":"RECRUITING","sponsor":"Quanovate Tech Inc.","startDate":"2024-05-01","conditions":"Menstrual Cycle Abnormal, Polycystic Ovary Syndrome, Athletes","enrollment":150},{"nctId":"NCT06637189","phase":"PHASE4","title":"Protocol with Progestin-primed Ovarian Stimulation (PPOS) from the Beginning of Stimulation Versus Protocol with GnRH Antagonists for Ovarian Stimulation in Patients Undergoing DUOSTIM with Embryo Accumulation for PGT-A.","status":"NOT_YET_RECRUITING","sponsor":"Ginefiv","startDate":"2024-10-15","conditions":"Stimulation in the Ovary, Embryo, Oocyte","enrollment":144},{"nctId":"NCT00703014","phase":"","title":"Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05787 (P05712)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-07-13","conditions":"Pregnancy, Neonates","enrollment":541},{"nctId":"NCT00702338","phase":"","title":"Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05693 (P05713)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2008-05-15","conditions":"Pregnancy, Neonates","enrollment":1},{"nctId":"NCT00702520","phase":"","title":"Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial 38833 (P05783)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-04-01","conditions":"Pregnancy, Neonates","enrollment":15},{"nctId":"NCT00702273","phase":"","title":"Follow-up Study of Frozen-thawed Embryo Transfer (FTET) Cycles After Cryopreservation of Embryos in Clinical Trial P05787 (P05716)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-04-19","conditions":"In Vitro Fertilization","enrollment":344},{"nctId":"NCT00702234","phase":"","title":"Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05714 (Care Program)(P05715)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-02-15","conditions":"Pregnancy, Neonates","enrollment":268},{"nctId":"NCT06571214","phase":"PHASE4","title":"Potential Benefit of r-hLH Addition in Patients Aged 35 to 40 Under Ovarian Stimulation Treatment","status":"NOT_YET_RECRUITING","sponsor":"Nanjing University","startDate":"2024-09-01","conditions":"Infertility","enrollment":300},{"nctId":"NCT06561594","phase":"PHASE3","title":"To Evaluate Recombinant Human Follicle Stimulating Hormone-CTP Fusion Protein Injection or Placebo Combined With Chorionic Gonadotropin for Injection","status":"NOT_YET_RECRUITING","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2024-09-20","conditions":"Idiopathic Hypogonadotropic Hypogonadism","enrollment":60},{"nctId":"NCT00598208","phase":"PHASE2","title":"A Phase 2, Trial to Investigate the Dose-Response Relationship of a Single Injection of Org 36286 (Corifollitropin Alfa) to Initiate Multiple Follicular Growth in a Controlled Ovarian (Study 38826)(P06055)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-05-19","conditions":"Fertilization","enrollment":325},{"nctId":"NCT00702585","phase":"PHASE2","title":"Study to Investigate the Optimal Dose of Org 36286 to Induce Monofollicular Ovulation in Women With WHO Group II Anovulatory Infertility (P07016)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2001-08-01","conditions":"Infertility","enrollment":55},{"nctId":"NCT00702806","phase":"PHASE2","title":"Investigate Dose of Org 36286 to Initiate Multiple Follicular Growth in a Controlled Ovarian Hyperstimulation Protocol for IVF or IVF/ICSI (P07015)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2001-07-01","conditions":"Infertility, In Vitro Fertilization","enrollment":99},{"nctId":"NCT00702195","phase":"","title":"Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established During Phase II Clinical Trials of Org 36286 (Study 38817)(P06054)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2002-01-01","conditions":"Pregnancy","enrollment":29},{"nctId":"NCT02890082","phase":"PHASE2","title":"Preservation of Fertility by Ovarian Stimulation Associated With Tamoxifen, Prior Chemotherapy for Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Institut Cancerologie de l'Ouest","startDate":"2014-02","conditions":"Breast Cancer","enrollment":102},{"nctId":"NCT06396390","phase":"PHASE4","title":"Comparison of Progestin Primed Ovarian Stimulation (PPOS) vs.GnRH Antagonist Methods on IVF Outcomes","status":"NOT_YET_RECRUITING","sponsor":"Nesta Clinic","startDate":"2024-08-01","conditions":"IVF, Fertility Issues, Infertility","enrollment":152},{"nctId":"NCT06486870","phase":"PHASE3","title":"Comparison Between Two Ovulation Induction Therapies and LOD on Clinical Outcomes in CC-Resistant PCOS Women","status":"COMPLETED","sponsor":"Cairo University","startDate":"2020-01-01","conditions":"PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries","enrollment":183},{"nctId":"NCT06481696","phase":"NA","title":"Possible Action of Resveratrol in Improving the Outcomes of IVF/ICSI in Couples With Unexplained Infertility","status":"RECRUITING","sponsor":"Andros Day Surgery Clinic","startDate":"2024-06-01","conditions":"Unexplained Infertility","enrollment":90},{"nctId":"NCT06480682","phase":"","title":"Relative Energy Deficiency in Sport and Dance","status":"NOT_YET_RECRUITING","sponsor":"University of Wolverhampton","startDate":"2024-09-10","conditions":"Relative Energy Deficiency in Sport, Bone Stress Reaction","enrollment":200},{"nctId":"NCT00696800","phase":"PHASE3","title":"A Study to Investigate the Efficacy and Safety of a Single Injection of Corifollitropin Alfa (Organon 36286) for Ovarian Stimulation Using Daily Recombinant Follicle Stimulating Hormone (FSH) as Reference (P05787)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-06-27","conditions":"In Vitro Fertilization","enrollment":1509},{"nctId":"NCT01146418","phase":"PHASE3","title":"Frozen-thawed Embryo Transfer (FTET) Cycle Follow-up Protocol (P06031)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2010-06-02","conditions":"Infertility","enrollment":307},{"nctId":"NCT00702845","phase":"PHASE3","title":"To Investigate Efficacy and Safety of a Single Injection of Org 36286 for Ovarian Stimulation Using Daily Recombinant FSH as Reference (Ensure)(P05690/MK-8962-001)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-12-28","conditions":"Infertility","enrollment":397},{"nctId":"NCT00696878","phase":"PHASE3","title":"Corifollitropin Alfa in Participants Undergoing Repeated Controlled Ovarian Stimulation (COS) Cycles Using a Multiple Dose Gonadatropin Releasing Hormone (GnRH) Antagonist Protocol (Study 38825)(P05714)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-09-26","conditions":"In Vitro Fertilization","enrollment":682},{"nctId":"NCT00697255","phase":"PHASE2","title":"A Phase 2 Trial to Evaluate if Corifollitropin Alfa (Org 36286), Followed by a Low Daily Dose of hCG or Recombinant FSH Can Induce Monofollicular Growth in Women With WHO Group II Anovulatory Infertility (P05693)","status":"TERMINATED","sponsor":"Organon and Co","startDate":"2007-05-15","conditions":"Ovulation Induction","enrollment":8}],"_emaApprovals":[],"_faersSignals":[{"count":23,"reaction":"OVARIAN HYPERSTIMULATION SYNDROME"},{"count":12,"reaction":"PROGESTERONE INCREASED"},{"count":10,"reaction":"ABORTION"},{"count":9,"reaction":"OFF LABEL USE"},{"count":8,"reaction":"ABORTION SPONTANEOUS"},{"count":8,"reaction":"DRUG EXPOSURE BEFORE PREGNANCY"},{"count":8,"reaction":"PREMATURE BABY"},{"count":7,"reaction":"DRUG EXPOSURE DURING PREGNANCY"},{"count":6,"reaction":"ECTOPIC PREGNANCY"},{"count":6,"reaction":"FOETAL EXPOSURE DURING PREGNANCY"}],"administration":{"route":"Oral"},"crossReferences":{"chemblId":"CHEMBL415111"},"_approvalHistory":[],"publicationCount":25227,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["buserelin, r-hFSH, r-hLH","buserelin, r-hFSH, HCG","Bravelle","Follistim","Gonal-F"],"phase":"marketed","status":"active","brandName":"follicle stimulating hormone","genericName":"follicle stimulating hormone","companyName":"Medical University of Vienna","companyId":"medical-university-of-vienna","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":2,"regulatoryByCountry":[{"country_code":"EU","regulator":"EMA","status":"approved","approval_date":"1995-10-20T00:00:00.000Z","mah":"Merck Europe B.V.","brand_name_local":"GONAL-f","application_number":"EMEA/H/C/000071"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":2,"withResults":0},"validation":{"fieldsValidated":1,"lastValidatedAt":"2026-04-20T06:04:52.641834+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}